Hims & Hers Health (HIMS) Return on Capital Employed (2020 - 2026)

Hims & Hers Health has disclosed Return on Capital Employed across 7 years of filings, most recently posting 1.92% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 1.92%, down 2309.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.92% (down 2309.0% YoY), and the FY2025 annual result was 10.29%, down 725.0% from the prior year.
• Return on Capital Employed came in at 1.92% for Q1 2026 at Hims & Hers Health, down from 5.9% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 21.16% in Q1 2025 to a low of 26.53% in Q2 2022.
• The 5-year median for Return on Capital Employed is 2.36% (2024), against an average of 4.95%.
• Across the five-year window, Return on Capital Employed surged 2377 bps in 2024 and sank 2309 bps in 2026, its largest moves.
• Hims & Hers Health's Return on Capital Employed stood at 21.03% in 2022, then surged by 59 bps to 8.69% in 2023, then surged by 264 bps to 14.28% in 2024, then tumbled by 59 bps to 5.9% in 2025, then plunged by 133 bps to 1.92% in 2026.
• The last three Return on Capital Employed figures came in at 1.92% (Q1 2026), 5.9% (Q4 2025), and 7.17% (Q3 2025), per Business Quant data.